Executive Summary
Market Research Methodology
2.1. Research methodology and design
2.2. Sample selection
2.3. Reliability and validity
Market Analysis
3.1. Market size and growth rates
3.2. Macroeconomic change
3.3. Market growth drivers, market dynamics and trends
3.4. Megatrends and their impact
3.5. Change and strategic drift
3.6. Value chain analysis
3.7. Distribution platforms
3.8. Market scenarios and opportunity forecasts
3.9. Relevant markets
3.10. The new frontiers of growth
3.11. Creating value through sustainable strategies
Industry Analysis
4.1. Supply chain analysis
4.2. Fixing the supply chain
4.3. Upstream and downstream business opportunities
4.4. Porter’s five forces analysis
4.5. PEST analysis
4.6. Forecast factors
4.7. Technology roadmap
4.8. Cost structure analysis
COVID 19 Crisis Analysis
5.1. Statistics and probable future impact
5.2. Scenarios and path forward
5.3. Sector specific impact
5.4. Industry transformation
5.5. Action plan for industry players
5.6. Supply chain: actions to consider
5.7. Initiatives prioritization
5.8. Strategic crisis-action plan
5.9. The next normal
5.9.1. Supply chain
5.9.2. Regulations
5.9.3. Organizations
Market Breakdownby Type
6.1. Introduction
6.2. Hemodialysis
6.3. Peritoneal Dialysis
Market Breakdown by Type
7.1. Introduction
7.2. Equipment
7.2.1. Dialysis Machines
7.2.2. Water Treatment Systems
7.2.3. Others
7.3. Consumables
7.3.1. Dialyzers
7.3.2. Catheters
7.3.3. Access Products
7.3.4. Concentrates
7.3.5. Others
7.4. Services
7.4.1. Acute dialysis
7.4.2. Chronic dialysis
Market Breakdown by End-Use
8.1. Introduction
8.2. In-Center Dialysis
8.3. Home Dialysis
Market Breakdown by Geography
9.1. Northeast
9.1.1. New England
9.1.2. Middle Atlantic
9.2. Midwest
9.2.1. East North Central
9.2.2. West North Central
9.3. South
9.3.1. South Atlantic
9.3.2. East South Central
9.3.3. West South Central
9.4. West
9.4.1. Mountain
9.4.2. Pacific
Competitive Landscape
10.1. Low-cost position
10.2. Competitive situation and trends
10.3. Competitive strategies
10.4. Marketing strategies
10.5. Industry benchmarking
10.6. Maintaining current market share
10.7. Extending volume growth
10.8. Expansion path
10.9. Recent market and industry developments
10.9.1. New product developments and announcements
10.9.2. Agreements, partnerships, joint ventures, and collaborations
10.9.3. Mergers and acquisitions and major PE deals
Companies Profiles/Cited
11.1. Asahi Kasei Corporation
11.2. American Renal Associates
11.3. B. Braun Melsungen AG
11.4. Baxter International Inc.
11.5. DaVita Inc.
11.6. Becton, Dickinson and Company
11.7. Fresenius Medical Care AG & Co.
11.8. Medtronic plc
11.9. Nipro Corporation
11.10. Sanderling Renal Services
11.11. Toray Industries Inc.
11.12. U.S. Renal Care, Inc.
11.13. Others